Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Visentin

Showing results (111-120 of 193) with videos related to

Pageof 20
Sort By:
Annals of Hematology|April 30, 2024
Impact of the presence and number of chromosomal abnormalities on the clinical outcome in Waldenström Macroglobulinemia: a monocentric experienceNicolò Danesin, Laura Bonaldi, Annalisa Martines, et al.
Haematologica|April 9, 2026
Disease course of <i>FLT3</i> mutated extramedullary acute myeloid leukemia and efficacy of gilteritinibFrancesco Angotzi, Erika Borlenghi, Chiara Sartor, et al.
Frontiers in Oncology|November 1, 2021
Protein Kinase CK1α Sustains B-Cell Receptor Signaling in Mantle Cell LymphomaSabrina Manni, Anna Fregnani, Laura Quotti Tubi, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 3, 2015
Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic LeukemiaAndrea Visentin, Monica Facco, Federica Frezzato, et al.
British Journal of Haematology|April 19, 2017
Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cellsVeronica Martini, Cristina Gattazzo, Federica Frezzato, et al.
Cancers|November 13, 2021
Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic LeukemiaFederica Frezzato, Andrea Visentin, Filippo Severin, et al.
Cancer Reports (Hoboken, N.J.)|April 25, 2024
When Waldenström macroglobulinemia hits the kidney: Description of a case series and management of a "rare in rare" scenarioNicolò Danesin, Greta Scapinello, Dorella Del Prete, et al.
Hematological Oncology|July 24, 2019
A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemiaAndrea Visentin, Marina Deodato, Francesca R Mauro, et al.
Journal of the Peripheral Nervous System : JPNS|January 24, 2026
Pachymeningeal Involvement in POEMS Syndrome: Longitudinal Follow-Up Study and Correlation With Therapeutic ResponseChiara Briani, Luca Massarotti, Antonio Branca, et al.
Leukemia & Lymphoma|July 3, 2020
Infections in patients with lymphoproliferative diseases treated with brentuximab vedotin: SEIFEM multicentric retrospective studyGessica Marchesini, Gianpaolo Nadali, Davide Facchinelli, et al.
Pageof 20

Showing results (111-120 of 193) with videos related to

Sort By:
Pageof 20
Annals of Hematology|April 30, 2024
Impact of the presence and number of chromosomal abnormalities on the clinical outcome in Waldenström Macroglobulinemia: a monocentric experienceNicolò Danesin, Laura Bonaldi, Annalisa Martines, et al.
Haematologica|April 9, 2026
Disease course of <i>FLT3</i> mutated extramedullary acute myeloid leukemia and efficacy of gilteritinibFrancesco Angotzi, Erika Borlenghi, Chiara Sartor, et al.
Frontiers in Oncology|November 1, 2021
Protein Kinase CK1α Sustains B-Cell Receptor Signaling in Mantle Cell LymphomaSabrina Manni, Anna Fregnani, Laura Quotti Tubi, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 3, 2015
Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic LeukemiaAndrea Visentin, Monica Facco, Federica Frezzato, et al.
British Journal of Haematology|April 19, 2017
Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cellsVeronica Martini, Cristina Gattazzo, Federica Frezzato, et al.
Cancers|November 13, 2021
Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic LeukemiaFederica Frezzato, Andrea Visentin, Filippo Severin, et al.
Cancer Reports (Hoboken, N.J.)|April 25, 2024
When Waldenström macroglobulinemia hits the kidney: Description of a case series and management of a "rare in rare" scenarioNicolò Danesin, Greta Scapinello, Dorella Del Prete, et al.
Hematological Oncology|July 24, 2019
A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemiaAndrea Visentin, Marina Deodato, Francesca R Mauro, et al.
Journal of the Peripheral Nervous System : JPNS|January 24, 2026
Pachymeningeal Involvement in POEMS Syndrome: Longitudinal Follow-Up Study and Correlation With Therapeutic ResponseChiara Briani, Luca Massarotti, Antonio Branca, et al.
Leukemia & Lymphoma|July 3, 2020
Infections in patients with lymphoproliferative diseases treated with brentuximab vedotin: SEIFEM multicentric retrospective studyGessica Marchesini, Gianpaolo Nadali, Davide Facchinelli, et al.
Pageof 20